ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 139 filers reported holding ANAPTYSBIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,620,220 | -37.4% | 145,892 | -29.1% | 0.00% | -25.0% |
Q2 2023 | $4,185,891 | -7.1% | 205,796 | -0.6% | 0.00% | -20.0% |
Q1 2023 | $4,505,451 | -16.5% | 207,052 | +18.9% | 0.01% | -16.7% |
Q4 2022 | $5,398,396 | +19.9% | 174,198 | -1.3% | 0.01% | +20.0% |
Q3 2022 | $4,503,000 | +69.2% | 176,500 | +34.6% | 0.01% | +66.7% |
Q2 2022 | $2,662,000 | -36.5% | 131,152 | -22.7% | 0.00% | -25.0% |
Q1 2022 | $4,195,000 | -43.2% | 169,560 | -20.3% | 0.00% | -33.3% |
Q4 2021 | $7,390,000 | +7.4% | 212,681 | -16.2% | 0.01% | 0.0% |
Q3 2021 | $6,883,000 | +2.6% | 253,792 | -1.9% | 0.01% | 0.0% |
Q2 2021 | $6,707,000 | +5.3% | 258,644 | -12.5% | 0.01% | 0.0% |
Q1 2021 | $6,370,000 | -47.6% | 295,594 | -47.7% | 0.01% | -45.5% |
Q4 2020 | $12,145,000 | +28.5% | 564,925 | -11.9% | 0.01% | +10.0% |
Q3 2020 | $9,454,000 | -39.5% | 640,946 | -8.4% | 0.01% | -47.4% |
Q2 2020 | $15,633,000 | +141.5% | 699,767 | +52.8% | 0.02% | +90.0% |
Q1 2020 | $6,473,000 | +9.0% | 458,061 | +25.4% | 0.01% | +42.9% |
Q4 2019 | $5,937,000 | -9.6% | 365,391 | +478.9% | 0.01% | -22.2% |
Q1 2018 | $6,569,000 | +1173.1% | 63,116 | +1130.8% | 0.01% | +800.0% |
Q4 2017 | $516,000 | +14.7% | 5,128 | -60.2% | 0.00% | 0.0% |
Q3 2017 | $450,000 | – | 12,882 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |